These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3015002)

  • 21. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.
    Roberts GB; Fyfe JA; Gaillard RK; Short SA
    J Virol; 1991 Dec; 65(12):6407-13. PubMed ID: 1658351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of herpes simplex virus-induced DNA polymerases and cellular DNA polymerase alpha by triphosphates of acyclic guanosine analogs.
    Larsson A; Sundqvist A; Parnerud AM
    Mol Pharmacol; 1986 Jun; 29(6):614-21. PubMed ID: 3012321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys of (R,S)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine, an anti-varicella-zoster virus drug.
    Lake-Bakaar DM; Abele G; Lindborg B; Soike KF; Datema R
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1807-12. PubMed ID: 2854453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
    Talarico CL; Phelps WC; Biron KK
    J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication.
    Larsson A; Oberg B; Alenius S; Hagberg CE; Johansson NG; Lindborg B; Stening G
    Antimicrob Agents Chemother; 1983 May; 23(5):664-70. PubMed ID: 6307131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
    Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acyclic guanosine analogs as inhibitors of human cytomegalovirus.
    Wahren B; Larsson A; Rudén U; Sundqvist A; Sølver E
    Antimicrob Agents Chemother; 1987 Feb; 31(2):317-20. PubMed ID: 3032096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir.
    Larsson A; Stenberg K; Ericson AC; Haglund U; Yisak WA; Johansson NG; Oberg B; Datema R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):598-605. PubMed ID: 3024562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
    Biron KK; Fyfe JA; Noblin JE; Elion GB
    Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
    Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
    J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
    Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
    Shigeta S; Yokota T
    Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
    Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
    Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella zoster virus deoxythymidine kinase is present in serum before the onset of varicella.
    Källander CF; Gronowitz JS; Olding-Stenkvist E
    Scand J Infect Dis; 1989; 21(3):255-7. PubMed ID: 2547243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mutant strain of varicella-zoster virus deficient in thymidine kinase-inducing activity.
    Yokota T; Ogata M; Shigeta S
    Fukushima J Med Sci; 1983 Jul; 29(3-4):101-11. PubMed ID: 6088377
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.
    Brunnemann AK; Bohn-Wippert K; Zell R; Henke A; Walther M; Braum O; Maschkowitz G; Fickenscher H; Sauerbrei A; Krumbholz A
    Antimicrob Agents Chemother; 2015 May; 59(5):2726-34. PubMed ID: 25712361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.
    Manfredini S; Baraldi PG; Durini E; Porcu L; Angusti A; Vertuani S; Solaroli N; De Clercq E; Karlsson A; Balzarini J
    Bioorg Med Chem Lett; 2001 May; 11(10):1329-32. PubMed ID: 11392548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.
    Neyts J; Andrei G; De Clercq E
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3285-9. PubMed ID: 9835529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.